{ "cik": 1297184, "cik_padded": "0001297184", "entityName": "Amphastar Pharmaceuticals, Inc.", "fiscal_years": [ { "accn": "0001297184-26-000009", "filed": "2026-02-26", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 75586000.0, "capex": 34882000.0, "cash": 170177000.0, "cost_of_revenue": 363830000.0, "eps_diluted": 2.03, "free_cash_flow": 121233000.0, "gross_profit": 356057000.0, "net_income": 98094000.0, "operating_cash_flow": 156115000.0, "operating_income": 140403000.0, "revenue": 719887000.0, "stockholders_equity": 788805000.0, "total_assets": 1629299000.0, "total_liabilities": 840494000.0 }, "period_end": "2025-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.494601236027321, "leverage": 1.0655282357490128, "net_margin": 0.13626305239572323, "operating_margin": 0.19503477629127905, "revenue_growth_yoy": -0.016503476249612344, "roa_avg2y": 0.061179336584580926, "roa_period_end": 0.060206260483803155, "roe_avg2y": 0.12897745912012534, "roe_period_end": 0.12435773099815543 } }, { "accn": "0001297184-26-000009", "filed": "2026-02-26", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 85458000.0, "capex": 41041000.0, "cash": 151609000.0, "cost_of_revenue": 358112000.0, "eps_diluted": 3.06, "free_cash_flow": 172345000.0, "gross_profit": 373855000.0, "net_income": 159519000.0, "operating_cash_flow": 213386000.0, "operating_income": 205419000.0, "revenue": 731967000.0, "stockholders_equity": 732298000.0, "total_assets": 1577470000.0, "total_liabilities": 845172000.0 }, "period_end": "2024-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.5107539001075185, "leverage": 1.1541367039101569, "net_margin": 0.2179319559488338, "operating_margin": 0.2806397009701257, "revenue_growth_yoy": 0.13589801286478015, "roa_avg2y": 0.10323578120763065, "roa_period_end": 0.10112331771761111, "roe_avg2y": 0.2325826207845776, "roe_period_end": 0.21783345031667437 } }, { "accn": "0001297184-26-000009", "filed": "2026-02-26", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 58144000.0, "capex": 38166000.0, "cash": 144296000.0, "cost_of_revenue": 293274000.0, "eps_diluted": 2.6, "free_cash_flow": 145337000.0, "gross_profit": 351121000.0, "net_income": 137545000.0, "operating_cash_flow": 183503000.0, "operating_income": 196987000.0, "revenue": 644395000.0, "stockholders_equity": 639421000.0, "total_assets": 1512912000.0, "total_liabilities": 873491000.0 }, "period_end": "2023-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.5448847368461891, "leverage": 1.3660655499271999, "net_margin": 0.21344827318647724, "operating_margin": 0.30569293678566717, "revenue_growth_yoy": 0.2914063893448126, "roa_avg2y": 0.1219965949694421, "roa_period_end": 0.0909140782808253, "roe_avg2y": 0.23550633133546617, "roe_period_end": 0.21510866862364544 } }, { "accn": "0001297184-26-000009", "filed": "2026-02-26", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 39909000.0, "capex": 24034000.0, "cash": 156098000.0, "cost_of_revenue": 250127000.0, "eps_diluted": 1.74, "free_cash_flow": 65147000.0, "gross_profit": 248860000.0, "net_income": 91386000.0, "operating_cash_flow": 89181000.0, "operating_income": 107497000.0, "revenue": 498987000.0, "stockholders_equity": 528658000.0, "total_assets": 741987000.0, "total_liabilities": 213329000.0 }, "period_end": "2022-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.49873042784681765, "leverage": 0.4035293138475158, "net_margin": 0.1831430478148729, "operating_margin": 0.21543046211624753, "revenue_growth_yoy": 0.13984347873759617, "roa_avg2y": 0.12930309950506397, "roa_period_end": 0.12316388292517252, "roe_avg2y": 0.18761625161674433, "roe_period_end": 0.1728641200927632 } }, { "accn": "0001297184-25-000008", "filed": "2025-03-03", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 28873000.0, "capex": 27456000.0, "cash": 126353000.0, "cost_of_revenue": 238029000.0, "eps_diluted": 1.25, "free_cash_flow": 70538000.0, "gross_profit": 199739000.0, "net_income": 62116000.0, "operating_cash_flow": 97994000.0, "operating_income": 69887000.0, "revenue": 437768000.0, "stockholders_equity": 445522000.0, "total_assets": 671529000.0, "total_liabilities": 226007000.0 }, "period_end": "2021-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.45626678971510026, "leverage": 0.50728583549185, "net_margin": 0.14189250927431882, "operating_margin": 0.1596439209809762, "revenue_growth_yoy": 0.2513162934548344, "roa_avg2y": 0.09536025300034925, "roa_period_end": 0.09249935594739765, "roe_avg2y": 0.13892389669497732, "roe_period_end": 0.1394229690116313 } }, { "accn": "0001297184-24-000009", "filed": "2024-02-29", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 24425000.0, "capex": 33855000.0, "cash": 92642000.0, "cost_of_revenue": 206506000.0, "eps_diluted": 0.03, "free_cash_flow": 23411000.0, "gross_profit": 143340000.0, "net_income": 1403000.0, "operating_cash_flow": 57266000.0, "operating_income": 10954000.0, "revenue": 349846000.0, "stockholders_equity": 448723000.0, "total_assets": 631236000.0, "total_liabilities": 182513000.0 }, "period_end": "2020-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.409723135322399, "leverage": 0.40673867842744854, "net_margin": 0.004010335976401045, "operating_margin": 0.03131091966179405, "revenue_growth_yoy": 0.08527502117217867, "roa_avg2y": 0.002303385221066699, "roa_period_end": 0.002222623551254998, "roe_avg2y": 0.0032022787991112136, "roe_period_end": 0.0031266505171341787 } }, { "accn": "0001297184-23-000019", "filed": "2023-03-01", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 22291000.0, "capex": 41555000.0, "cash": 73685000.0, "cost_of_revenue": 190434000.0, "eps_diluted": 0.98, "free_cash_flow": 207000.0, "gross_profit": 131923000.0, "net_income": 48939000.0, "operating_cash_flow": 41762000.0, "operating_income": -39000.0, "revenue": 322357000.0, "stockholders_equity": 427528000.0, "total_assets": 586971000.0, "total_liabilities": 159443000.0 }, "period_end": "2019-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.4092450295790071, "leverage": 0.3729416552833966, "net_margin": 0.15181615413966504, "operating_margin": -0.00012098387812270249, "revenue_growth_yoy": 0.09397419451175229, "roa_avg2y": 0.0889368252139416, "roa_period_end": 0.08337549895991454, "roe_avg2y": 0.12360096831997494, "roe_period_end": 0.11446969555210419 } }, { "accn": "0001297184-22-000007", "filed": "2022-03-11", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 25047000.0, "capex": 46808000.0, "cash": 86337000.0, "cost_of_revenue": 187681000.0, "eps_diluted": -0.12, "free_cash_flow": -8617000.0, "gross_profit": 106985000.0, "net_income": -5738000.0, "operating_cash_flow": 38191000.0, "operating_income": -8623000.0, "revenue": 294666000.0, "stockholders_equity": 364359000.0, "total_assets": 513563000.0, "total_liabilities": 149204000.0 }, "period_end": "2018-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.36307208839839006, "leverage": 0.4094972266363669, "net_margin": -0.01947289473505596, "operating_margin": -0.029263640867965766, "revenue_growth_yoy": 0.22688039970854584, "roa_avg2y": -0.011896727777864166, "roa_period_end": -0.011172923283024671, "roe_avg2y": -0.016439023342095273, "roe_period_end": -0.015748204380844167 } }, { "accn": "0001297184-21-000008", "filed": "2021-03-15", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 30747000.0, "capex": 35099000.0, "cash": 65594000.0, "cost_of_revenue": 149666000.0, "eps_diluted": 0.08, "free_cash_flow": 4110000.0, "gross_profit": 90509000.0, "net_income": 3647000.0, "operating_cash_flow": 39209000.0, "operating_income": -1269000.0, "revenue": 240175000.0, "stockholders_equity": 333736000.0, "total_assets": 451072000.0, "total_liabilities": 117336000.0 }, "period_end": "2017-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.3768460497553867, "leverage": 0.35158328738883426, "net_margin": 0.015184761111689394, "operating_margin": -0.005283647340480899, "revenue_growth_yoy": -0.05874630141281132, "roa_avg2y": 0.00829986003800594, "roa_period_end": 0.008085183740068105, "roe_avg2y": 0.011047179970284388, "roe_period_end": 0.010927799218543999 } }, { "accn": "0001297184-20-000007", "filed": "2020-03-16", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 9908000.0, "capex": 21382000.0, "cash": 72354000.0, "cost_of_revenue": 150969000.0, "eps_diluted": 0.21, "free_cash_flow": 17178000.0, "gross_profit": 104196000.0, "net_income": 9820000.0, "operating_cash_flow": 38560000.0, "operating_income": 15376000.0, "revenue": 255165000.0, "stockholders_equity": 326523000.0, "total_assets": 427738000.0, "total_liabilities": 98483000.0 }, "period_end": "2016-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.40834753982717065, "leverage": 0.3016112188115385, "net_margin": 0.038484901926204615, "operating_margin": 0.060259048066937076, "roa_period_end": 0.02295797894973091, "roe_period_end": 0.030074451110641512 } } ], "latest_filing": { "accn": "0001297184-26-000009", "filed": "2026-02-26", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001297184.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001297184.json" }, "ticker": "AMPH" }